TITAN PHARMACEUTICALS INC | Business Contracts

Fifth Amended and Restated 2015 Omnibus Equity Incentive Plan (subject to stockholder approval) (Filed With SEC on November 14, 2022)

Form of Stock Option Agreement (Filed With SEC on November 14, 2022)

Placement Agency Agreement (Filed With SEC on February 3, 2022)

Agreement for Co-Promotion Partnership, dated June 23, 2020, by and between Titan Pharmaceuticals, Inc. and Indegene, Inc (Filed With SEC on August 14, 2020)

Form of Stock Option Agreement (Filed With SEC on September 21, 2022)

Form of Amendment to Employment Agreement with Kate DeVarney (Filed With SEC on August 5, 2022)

Form of Amendment to Employment Agreement with Marc Rubin (Filed With SEC on August 5, 2022)

Form of Securities Purchase Agreement (Filed With SEC on February 3, 2022)

Form of Placement Warrant (Filed With SEC on February 3, 2022)

Form of Private Pre-Funded Warrant (Filed With SEC on February 3, 2022)

Form of Registered Pre-Funded Warrant (Filed With SEC on February 3, 2022)

Amendment No. 2 to Employment Agreement dated April 2, 2019 between the registrant and Marc Rubin (Filed With SEC on October 28, 2021)

Form of Warrant (Filed With SEC on January 19, 2021)

Placement Agency Agreement (Filed With SEC on January 19, 2021)

Form of Securities Purchase Agreement (Filed With SEC on January 19, 2021)

Asset Purchase Agreement dated October 27, 2020 between Titan Pharmaceuticals, Inc. and JT Pharmaceuticals, Inc (Filed With SEC on November 16, 2020)

Underwriting Agreement dated October 28, 2028 between Titan Pharmaceuticals, Inc. and Maxim Group LLC (Filed With SEC on November 2, 2020)

Form of Lock-Up and Voting Agreement (Filed With SEC on October 27, 2020)

Warrant Agency Agreement between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company and Form of Warrant (Filed With SEC on October 27, 2020)

Form of Lock-Up and Voting Agreement (Filed With SEC on October 26, 2020)

Warrant Agency Agreement between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company and Form of Warrant (Filed With SEC on October 26, 2020)

Debt Settlement and Release Agreement (Filed With SEC on October 26, 2020)

Warrant Agency Agreement between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company and Form of Warrant (Filed With SEC on October 19, 2020)

Underwriting Agreement between Titan Pharmaceuticals, Inc. and Maxim Group LLC (Filed With SEC on October 19, 2020)

Form of Share Purchase Agreement (Filed With SEC on September 25, 2020)

Placement Agency Agreement (Filed With SEC on September 25, 2020)

Amendment No. 2 dated March 12, 2020 to Amended and Restated Venture Loan and Security Agreement, dated March 21, 2018, by and between Titan Pharmaceuticals, Inc., Horizon... (Filed With SEC on March 30, 2020)

Description of the Registrants Common Stock (Filed With SEC on March 30, 2020)

Form of March 3, 2020 Warrant Amendment Agreement (Filed With SEC on March 30, 2020)

Placement Agency Agreement (Filed With SEC on January 7, 2020)

Form of Securities Purchase Agreement (Filed With SEC on January 7, 2020)

Form of Warrant (Filed With SEC on January 7, 2020)

Underwriting Agreement dated October 16, 2019 between Titan Pharmaceuticals, Inc. and Maxim Group LLC (Filed With SEC on October 18, 2019)

Class B Warrant Agency Agreement dated October 16, 2019 between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company (including Form of Class B Warrant) (Filed With SEC on October 18, 2019)

Form of 2019 Class C Warrant Agency Agreement between Titan Pharmaceuticals, Inc. and Continental Stock Transfer and Trust Company and Form of Class C Warrant (Filed With SEC on October 8, 2019)

Form of 2019 Class B Warrant Agency Agreement between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company and Form of Class B Warrant (Filed With SEC on October 8, 2019)

Form of Underwriting Agreement between Titan Pharmaceuticals, Inc. and Maxim Group LLC (Filed With SEC on October 8, 2019)

Form of Underwriting Agreement between Titan Pharmaceuticals, Inc. and Maxim Group LLC (Filed With SEC on September 12, 2019)

Form of Pre-Funded Warrant (Filed With SEC on September 12, 2019)

Amendment dated September 10, 2019 to Amended and Restated Venture Loan and Security Agreement, dated March 21, 2018, by and between Titan Pharmaceuticals, Inc., Horizon... (Filed With SEC on September 12, 2019)

Form of 2019 Warrant Agency Agreement between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company and Form of Offering Warrant (Filed With SEC on September 12, 2019)

Amendment No. 2 dated September 10, 2019 to Asset Purchase, Supply and Support Agreement by and between Titan Pharmaceuticals, Inc. and L. Molteni & C. Dei Frattelli Alitti Societ... (Filed With SEC on September 12, 2019)

Placement Agency Agreement (Filed With SEC on August 8, 2019)

Form of Securities Purchase Agreement (Filed With SEC on August 8, 2019)

Form of Placement Warrant (Filed With SEC on August 8, 2019)

Form of Pre-Funded Warrant (Filed With SEC on August 8, 2019)

Sales Agreement dated April 25, 2019 between the Registrant and A.G.P./Alliance Global Partners (Filed With SEC on April 26, 2019)

Employment Agreement between the Registrant and Sunil Bhonsle (Filed With SEC on April 3, 2019)

Employment Agreement between the Registrant and Marc Rubin (Filed With SEC on April 3, 2019)

Employment Agreement between the Registrant and Katherine Beebe DeVarney (Filed With SEC on April 1, 2019)

Employment Agreement between the Registrant and Dane Hallberg (Filed With SEC on April 1, 2019)

Third Amended and Restated 2015 Omnibus Equity Incentive Plan (Filed With SEC on January 25, 2019)

TITAN PHARMACEUTICALS INC (52)